Roy Winston

CIK 1751757 · View on SEC EDGAR ↗

Insider

First SEC filing: Sept. 7, 2018 · Latest: Sept. 7, 2018

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 18 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

18 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Aug. 2, 2023 PCRX S 509 $34.88 $17,754 52,440 Direct -0.96% Disposed -30.9% (price as of 2026-08-20)
June 7, 2023 PCRX S 1,857 $37.86 $70,306 41,356 Direct -4.30% Disposed -36.4% (price as of 2026-08-20)
June 6, 2023 PCRX S 1,779 $38.99 $69,363 43,213 Direct -3.95% Disposed -38.2% (price as of 2026-08-20)
Aug. 3, 2022 PCRX S 476 $55.70 $26,513 44,992 Direct -1.05% Disposed -56.8% (price as of 2026-08-20)
June 6, 2022 PCRX S 10b5-1 123 $63.69 $7,834 35,160 Direct -0.35% Disposed -62.2% (price as of 2026-08-20)
June 6, 2022 PCRX S 10b5-1 1,891 $62.48 $118,150 35,283 Direct -5.09% Disposed -61.5% (price as of 2026-08-20)
June 6, 2022 PCRX S 10b5-1 3,650 $61.59 $224,804 37,174 Direct -8.94% Disposed -60.9% (price as of 2026-08-20)
June 6, 2022 PCRX S 10b5-1 3,533 $60.55 $213,923 40,824 Direct -7.96% Disposed -60.2% (price as of 2026-08-20)
June 6, 2022 PCRX S 10b5-1 115 $63.40 $7,291 44,357 Direct -0.26% Disposed -62.0% (price as of 2026-08-20)
June 6, 2022 PCRX S 10b5-1 1,300 $62.43 $81,159 44,472 Direct -2.84% Disposed -61.4% (price as of 2026-08-20)
June 6, 2022 PCRX S 10b5-1 2,300 $61.59 $141,657 45,772 Direct -4.78% Disposed -60.9% (price as of 2026-08-20)
June 6, 2022 PCRX S 10b5-1 2,535 $60.55 $153,494 48,072 Direct -5.01% Disposed -60.2% (price as of 2026-08-20)
June 6, 2022 PCRX S 10b5-1 2,099 $61.37 $128,816 44,357 Direct -4.52% Disposed -60.8% (price as of 2026-08-20)
June 4, 2021 PCRX S 2,276 $61.04 $138,927 24,035 Direct -8.65% Disposed -60.5% (price as of 2026-08-20)
March 31, 2021 PCRX S 10b5-1 1,200 $72.12 $86,544 26,311 Direct -4.36% Disposed -66.6% (price as of 2026-08-20)
March 31, 2021 PCRX S 10b5-1 4,661 $71.09 $331,350 27,511 Direct -14.49% Disposed -66.1% (price as of 2026-08-20)
March 31, 2021 PCRX S 10b5-1 16,363 $70.36 $1,151,301 32,172 Direct -33.71% Disposed -65.8% (price as of 2026-08-20)
Nov. 13, 2020 PCRX S 10b5-1 5,000 $62.00 $310,000 34,785 Direct -12.57% Disposed -61.2% (price as of 2026-08-20)
March 11, 2020 PCRX P 2,500 $36.50 $91,250 25,237 Direct +11.00% Acquired -34.0% (price as of 2026-08-20)
June 4, 2019 PCRX S 722 $42.91 $30,981 16,539 Direct -4.18% Disposed -43.9% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 14, 2023 PCRX Stock Option (Right to Buy) Common Stock (27,500) $38.74 June 14, 2033 27,500 Acquired
June 8, 2022 PCRX Stock Option (Right to Buy) Common Stock (24,800) $59.39 June 8, 2032 24,800 Acquired
June 6, 2022 PCRX Stock Option (Right to Buy) Common Stock (6,250) $34.38 May 2, 2028 6,250 Disposed
Nov. 4, 2021 PCRX Stock Option (Right to Buy) Common Stock (10,000) $48.15 May 2, 2027 10,000 Disposed
Aug. 3, 2021 PCRX Stock Option (Right to Buy) Common Stock (10,000) $60.79 July 20, 2031 10,000 Acquired
June 9, 2021 PCRX Stock Option (Right to Buy) Common Stock (17,500) $60.96 June 9, 2031 17,500 Acquired
March 31, 2021 PCRX Stock Option (Right to Buy) Common Stock (13,750) $34.38 May 2, 2028 13,750 Disposed
June 9, 2020 PCRX Stock Option (Right to Buy) Common Stock (35,000) $47.65 June 9, 2030 35,000 Acquired
June 5, 2019 PCRX Stock Option (Right to Buy) Common Stock (33,800) $43.54 June 5, 2029 33,800 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 7 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Sept. 7, 2018 PCRX Common Stock 16,500 Direct
Sept. 7, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (37,500) 37,500 Direct
Sept. 7, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (20,000) 20,000 Direct
Sept. 7, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (10,000) 10,000 Direct
Sept. 7, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (6,000) 6,000 Direct
Sept. 7, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (25,000) 25,000 Direct
Sept. 7, 2018 PCRX Stock Option (Right to Buy)→ Common Stock (10,000) 10,000 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

PCRX

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2019 $408,654 $225,000 $243,824 $720,919 — — $13,403 $1,611,800

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.